scispace - formally typeset
S

Steven H. Reynolds

Researcher at National Institute for Occupational Safety and Health

Publications -  58
Citations -  3139

Steven H. Reynolds is an academic researcher from National Institute for Occupational Safety and Health. The author has contributed to research in topics: Carcinogenesis & Gene. The author has an hindex of 31, co-authored 58 publications receiving 2960 citations. Previous affiliations of Steven H. Reynolds include Johns Hopkins University School of Medicine & University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

Activated Oncogenes in B6C3F1 Mouse Liver Tumors: Implications for Risk Assessment

TL;DR: The B6C3F1 mouse liver may provide a sensitive assay system to detect various classes of proto-oncogenes that are susceptible to activation by carcinogenic insult and will provide information at a molecular level to aid in the use of rodent carcinogenesis data for risk assessment.
Journal ArticleDOI

Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse.

TL;DR: A marked difference in the presence of activated oncogenes in spontaneous rat tumors versus spontaneous mouse liver tumors was observed in this study, suggesting the B6C3F1 mouse liver system might provide a very sensitive assay not only for assessing the potential of a chemical to activate a cellular proto-oncogene, but also for detecting various classes of proto- oncogenees that are susceptible to mutational activation.
Journal ArticleDOI

Induction of aneuploidy by single-walled carbon nanotubes.

TL;DR: These results are the first to report disruption of the mitotic spindle by single‐walled carbon nanotubes, and the nanotube bundles are similar to the size of microtubules that form the mitotics and may be incorporated into the mitosis spindle apparatus.
Journal ArticleDOI

DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.

TL;DR: Stable transfer of DLC-1 abolished tumorigenicity in nude mice of two cell lines, suggesting that DLC- 1 plays a role in NSCLC by acting as a bona fide new tumor suppressor gene.